Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹6Cr
Rev Gr TTM
Revenue Growth TTM
681.60%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

PADMAIND
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -435.7 | -100.0 | | | 227.7 | | | | 308.3 | 0.0 | -100.0 | 2,471.4 |
| -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 7 |
Operating Profit Operating ProfitCr |
| -10.6 | | | | 8.3 | -50.0 | 8.0 | 7.1 | 2.9 | -8.3 | | 3.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | 105.2 | 0.0 | 0.0 | -400.0 | -75.0 | -700.0 | 200.0 | 120.0 | 600.0 | 75.0 | -2,000.0 | 2,100.0 |
| -8.5 | | | | 1.7 | -66.7 | 4.0 | 3.6 | 2.9 | -16.7 | | 3.1 |
| 0.1 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | 0.0 | 0.0 | 0.1 | 0.0 | -0.3 | 0.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | | 741.7 | 125.0 | -100.0 | | | | -100.0 | | 419.9 | 215.5 |
| 0 | 0 | 2 | 5 | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 9 |
Operating Profit Operating ProfitCr |
| | -56.0 | -6.3 | -9.3 | | | | -519.9 | | -3.6 | 1.5 | 3.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 1 | 0 | -4 | -7 | -1 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | -5 | -7 | -2 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
| -34,151.9 | -33.5 | 72.0 | 1,734.8 | -155.3 | -3,573.7 | -59.0 | 78.7 | 99.9 | -3,776.3 | 125.5 | 447.9 |
| | -22.8 | -0.8 | 5.5 | | | | -1,162.9 | | -9.6 | 0.5 | 0.8 |
| -0.1 | -0.1 | 0.0 | 0.4 | -0.2 | -7.6 | -12.1 | -2.6 | 0.0 | -0.1 | 0.0 | 0.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| 0 | 0 | 0 | 8 | 8 | 3 | -5 | -6 | -6 | -6 | -6 | -6 |
Current Liabilities Current LiabilitiesCr | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 3 | 0 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 4 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1 | 1 | 2 | 11 | 2 | 1 | 0 | 0 | 1 | 1 | 4 | 1 |
Non Current Assets Non Current AssetsCr | 4 | 4 | 4 | 4 | 14 | 10 | 3 | 1 | 0 | 0 | 0 | 3 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 0 | 0 | -1 | -8 | 1 | -3 | -8 | -1 | -1 | 0 | -3 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 1 | -2 | 3 | 8 | 1 | 1 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 0 | 0 | 1 | 9 | 1 | 0 | 0 | 1 | 0 | 0 | 3 |
|
Free Cash Flow Free Cash FlowCr | 0 | 0 | 0 | -9 | 1 | -3 | -8 | -1 | -1 | 0 | -3 |
| 79.0 | 59.0 | 4,484.9 | -3,683.9 | -523.7 | 57.5 | 105.3 | 88.8 | 77,999.1 | -10.7 | -19,461.6 |
CFO To EBITDA CFO To EBITDA% | 80.6 | 24.0 | 542.3 | 2,176.7 | -329.1 | 767.1 | 3,698.3 | 198.7 | 1,333.0 | -28.1 | -6,190.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 7 | 10 | 22 | 59 | 66 | 5 | 3 | 2 | 2 | 3 | 4 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 257.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 313.0 |
Price To Sales Price To Sales | | 47.5 | 11.9 | 14.4 | | | | 16.8 | | 4.5 | 1.2 |
Price To Book Price To Book | 1.7 | 2.4 | 5.0 | 4.3 | 4.9 | 0.5 | 1.7 | -386.0 | -297.0 | -44.2 | -78.3 |
| -204.3 | -85.9 | -195.1 | -151.7 | -332.1 | -13.5 | -15.0 | -4.1 | -27.8 | -151.2 | 157.8 |
Profitability Ratios Profitability Ratios |
| | 4.5 | 0.4 | 1.9 | | | | -425.9 | | 18.7 | 7.4 |
| | -56.0 | -6.3 | -9.3 | | | | -519.9 | | -3.6 | 1.5 |
| | -22.8 | -0.8 | 5.5 | | | | -1,162.9 | | -9.6 | 0.5 |
| -0.8 | -1.1 | -0.3 | 1.9 | -0.9 | -49.7 | -353.6 | -259.9 | -0.2 | -10.4 | 0.1 |
| -0.8 | -1.1 | -0.3 | 1.7 | -0.9 | -51.9 | -470.2 | 42,778.2 | 28.6 | 91.7 | -30.6 |
| -0.7 | -0.9 | -0.2 | 1.6 | -0.8 | -42.7 | -247.9 | -97.5 | -0.1 | -3.7 | 0.4 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Padmanabh Industries Limited is an Indian public entity listed on the **Bombay Stock Exchange (BSE)**. Historically rooted in the **Fabrics business**, the company is currently undergoing a fundamental strategic pivot. While its constitutional documents outline a broad mandate in **Specialty Chemicals** and **Pharmaceuticals**, its recent operational focus has shifted toward the **trading of Agriculture goods, Commodities, and Agri Materials**.
The company operates under a **single reportable segment** model in accordance with **Ind AS**. Management has consolidated operations to function as a unified entity to streamline the ongoing business revival and financial reorganization.
---
### **Product Portfolio and Industrial Scope**
The company’s operational framework encompasses the entire lifecycle of chemical and commodity trade, from manufacturing and refining to import-export and domestic distribution.
| Segment | Core Activities |
| :--- | :--- |
| **Agri-Commodities** | Trading of agricultural goods and raw materials. |
| **Dyes & Pigments** | Production and sale of synthetic and non-synthetic dyes for industrial applications. |
| **Intermediates** | Manufacturing of **dye intermediates** and **coal-tar** derivatives. |
| **Specialty Chemicals** | Production of **surface-active agents** (surfactants) and industrial chemicals. |
| **Healthcare Inputs** | Manufacturing and dealing in **pharmaceutical** compounds and related inputs. |
**Operational Capabilities:**
* **Technical Processing:** Expertise in the **refining and manipulation** of raw chemical materials into value-added industrial outputs.
* **Supply Chain Integration:** Integrated capabilities in **buying, importing, and exporting** across the chemical and agricultural sectors.
---
### **Capital Restructuring: The 98% "Balance Sheet Clean-up"**
The defining feature of Padmanabh Industries' current strategy is a massive financial reorganization aimed at addressing historical **accumulated losses**. This "reset" is designed to align the company's capital structure with its actual asset value to facilitate fresh capital infusion.
**The Scheme of Reduction of Capital:**
Under **Section 66 of the Companies Act, 2013**, the company received shareholder approval on **September 30, 2024**, for a drastic capital reduction.
| Metric | Pre-Reduction | Post-Reduction (Proposed/Final) |
| :--- | :--- | :--- |
| **Total Equity Shares** | **60,77,500** | **1,21,550** |
| **Face Value per Share** | **Rs. 10** | **Rs. 10** |
| **Paid-up Share Capital** | **Rs. 6,07,75,000** | **Rs. 12,15,500** |
| **Capital Reduction %** | - | **98%** |
| **Losses Written Off** | - | **Rs. 5,95,59,500** |
* **Share Consolidation:** Shareholders receive **2 equity shares** for every **100 equity shares** previously held.
* **Regulatory Status:** As of late **2025**, the final approval from the **National Company Law Tribunal (NCLT) Ahmedabad Bench** is in the process of being finalized.
* **Strategic Goal:** Management believes this reduction is a prerequisite for attracting **Foreign Direct Investment (FDI)** and fresh funding, which was previously hindered by the loss-heavy balance sheet.
---
### **Financial Performance and Asset Management**
The company’s financial profile has been characterized by extreme volatility and a total liquidation of inventory to settle obligations.
**Comparative Financial Highlights (Rs. in Lakhs):**
| Particulars | FY 2024-25 (As at 31st March) | FY 2023-24 (As at 31st March) | FY 2022-23 (As at 31st March) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | - | **5,956.33** | **0.00** |
| **Other Income** | - | **72.09** | **1,274.93** |
| **Total Debts** | **350.83** | **60.99** | - |
| **Total Equity** | **-4.77** | **-6.23** | - |
| **Employee Benefit Expenses** | - | **270.01** | **486.00** |
**Key Financial Observations:**
* **Inventory Liquidation:** The company cleared its entire inventory of finished goods, which stood at **Rs. 4,841.29 Lakhs** at the start of **FY24**, resulting in **zero inventory** by the end of that cycle.
* **Gearing and Liquidity:** The company reports a negative **Total Equity** of **Rs. 4.77 Lakhs** against **Total Debts** of **Rs. 350.83 Lakhs**. Capital management is currently focused exclusively on maintaining **"Going Concern"** status.
* **Asset Base:** The company owns **no immovable properties**. It relies on an **annual physical verification** program for its existing Property, Plant, and Equipment.
---
### **Leadership and Governance Restructuring**
To oversee the post-restructuring revival, the company underwent a comprehensive board overhaul in **2024 and 2025**.
**Current Board Composition (as of August 2025):**
* **Mr. Dhairya Bharatbhai Shah (Managing Director):** Appointed **July 23, 2025**, for a **5-year term**. He is tasked with leading the business development phase following the NCLT clearances.
* **Mr. Umesh Parghi (CFO):** Assumed the role on **August 13, 2025**, to manage the restructured financial framework.
* **Independent Oversight:** **Mr. Rahul Parmar** and **Mr. Harpalsinh Parmar** were appointed as **Independent Directors** in **July 2025** to ensure regulatory compliance during the transition.
---
### **Critical Risk Factors and Audit Qualifications**
Investors should note significant "Material Weaknesses" identified in recent audits regarding internal controls and statutory compliance.
**1. Regulatory and Tax Non-Compliance:**
* **GST Inactivity:** The company’s **GST number has been inactive** for an extended period. No **GST returns** have been filed, making it impossible for auditors to verify reported **turnover** against statutory records.
* **Audit Qualifications:** Auditors have expressed uncertainty regarding the **valuation and verification of Intangible Assets**, which may materially misstate the balance sheet.
**2. Internal Control Deficiencies:**
* **IT and Policy Gaps:** There is a lack of documented policies and inadequate **IT controls**, creating a risk of **management override**, collusion, or fraud.
* **Risk Management:** The company lacks a formal **Risk Management Policy**, as management historically viewed business threats as minimal—a stance currently under scrutiny given the company's financial state.
**3. Market and Operational Pressures:**
* **Working Capital Intensity:** The legacy fabric and current trading businesses are highly **working capital intensive**. The company is sensitive to **interest rate hikes** and credit availability.
* **Credit Risk:** The company faces significant exposure if counterparties fail to meet obligations, managed currently through **aging analysis** of receivables.
* **Dependency on NCLT:** The entire growth thesis is contingent upon the successful legal execution of the **Capital Reduction** scheme. Failure to receive final orders would jeopardize the revival plan.